Deep Science Ventures — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB
Ali Afshar(Founder/CEO)inIgnacio Willats(Founder)in
Co-investorsY CombinatorAcequia Capital (AceCap)Artis VenturesEmles Venture PartnersIQ CapitalKinled Holding+4 more
Parallel Carbon develops hardware technology to produce low-cost hydrogen, renewable fuels, and chemicals such as fertilizers and methanol as alternatives to fossil fuels.
CleantechClimate TechEnergyJersey City, US
Aranzazu Carmona Orbezo(Executive Officer, Director, Promoter)Ryan Anderson(Executive Officer, Director, Promoter)
BoardAndrew Shebbeare(Director)in
Co-investorsAxon Partners GroupCounteract OneAramco Ventures
Rhizocore Technologies develops mycorrhizal fungal inoculum products to enhance plant growth, woodland restoration, and ecosystem resilience.
AgTechBiotechCleantechClimate TechImpact & Social GoodEdinburgh, GB
Toby Parkes(Founder)inToby Philip Parkes(Director)David Christopher Satori(Director)Jack Hooper(Chief Operating Officer)
BoardDaniel Fitzgerald(Director)
Co-investorsCollaborative FundGrosvenor EstateOld College CapitalScottish Enterprise
Xonai provides a Spark plugin that accelerates data processing workloads by compiling query execution and optimizing hardware utilization, reducing compute costs and energy consumption for enterprises running analytics on Spark clusters.
Cloud ComputingData & InfrastructureEnterprise Software
Co-investorsNauta CapitalAdara VenturesKadmos CapitalNotion Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.